Home Nav
Nextech Invest Logo

Carmen Diez

Alfred Scheidegger

Prior to joining Nextech in 2018, Dr. Diez worked as a Postdoctoral Researcher at University Children’s Hospital Zurich, where she specialized on the development of novel therapies for metabolic rare disorders and cancer. In parallel, she worked part time as private equity analyst at HBM Partners (Switzerland). She received the M.Sc. degree in Medical Biotechnology and Ph.D in Biotechnology from Universidad Politécnica de Valencia, Spain. Throughout her studies, she gained international experience in specific areas of biomedicine at KTH Biotechnology (with Prof. Mathias Uhlén), Bergen University and University Children’s Hospital Zurich (Switzerland).

 

J.P. Morgan 37th Annual Healthcare Conference

07.01. – 10.01.2019

San Francisco, CA, USA

  • 26.12.2018

    Tracon Pharmaceuticals Presents Positive Top-line Clinical...

  • 21.12.2018

    Tracon Pharmaceuticals Announces Top-line Data from...

  • 07.12.2018

    Arvinas Presents Preclinical Data on Protein Degrader,...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close